The German healthcare system is undergoing many changes: New regulations, advanced therapies, demographic trends, and rising costs are just a few of them. The offer of innovative treatment options on one side and the principle of contributory stability on the other side pose major challenges for all healthcare stakeholders. The positions and objectives of politics, pharmaceutical industry, payers and associations often seem to be incompatible.
Goals of the institute are an optimal cost-benefit ratio and constructive cooperation of all stakeholders in the healthcare sector. We advise you based on many years of experience – competently and independently.